Comparing consultative versus collaborative ways patients, clinicians, and the public partner with health teams.
Official title: Participatory Approach to Qualitative Research (PAQ): Comparing Two Methods of Engaging Stakeholders in Qualitative Research
Run by Dartmouth-Hitchcock Medical Center · NCT06838689 · Data updated 2026-11-12
This project will test whether a consultative or a collaborative way of involving patients, care partners, clinicians, and community members leads to better engagement and trust when they work with research teams on qualitative projects about pediatric mental health, cancer screening, and serious illness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 136 (estimated) |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 2 sites (Hanover, New Hampshire and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | August 30, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | November 19, 2025 |
| Trial ID | NCT06838689 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who can communicate in English, are able to use a computer or smartphone, and who have lived experience or professional roles relevant to pediatric mental health, cancer screening, or serious illness (including patients, care partners, clinicians, teachers, and community members) are ideal candidates.
✕Probably not a fit
Children below the age thresholds, people who cannot communicate in English, those unable to provide consent or to use a computer or smartphone, and prisoners are not eligible and unlikely to receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a stratified randomized trial that assigns patient, public, and clinician involvement (PPCI) participants to either a Consultative or a Collaborative approach while they work on one of three real qualitative interview projects (pediatric mental health, cancer screening, or serious illness). Participants will be engaged across study stages including design, data collection, analysis, and dissemination using detailed guides for each PPCI approach. The trial measures partner-reported outcomes such as engagement, trust, and patient-centeredness of the research. The investigators hypothesize the Collaborative approach will yield higher engagement, trust, and patient-centeredness, particularly among historically underrepresented groups.
Why it matters
Potential benefit: If successful, the findings could make health research more patient-centered and trustworthy so study results better reflect the needs and experiences of diverse communities.
How similar studies have gone: According to the investigators, this appears to be the first randomized trial comparing PPCI approaches, with prior support coming mainly from theory and observational or non-randomized work.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria \& Exclusion criteria across three sub-specialties: Pediatric mental health Inclusion: * Adults aged ≥18 years * Can communicate in English * Able to take part in research activities via a computer or a smartphone * Patients, care partners, clinicians, other healthcare professionals, teachers and school staff, health policy experts, and community members * Has lived experience or professional expertise relating to pediatric mental health Exclusion: * Children \<18 years * Cannot communicate in English * Adults unable to provide verbal consent * Prisoners * Unable to take part in research activities via a computer or a smartphone Generalized cancer screening Inclusion: * Adults aged ≥21 years * Can communicate in English * Able to take part in research activities via a computer or a smartphone * Patients, care partners, clinicians, other healthcare professionals, health policy experts, and community members * Is eligible for population-based cancer screening tests (breast, prostate, cervical, colorectal cancer), or has lived experience or professional expertise relating to generalized cancer screening Exclusion: * Children \<18 years * Cannot communicate in English * Adults unable to provide verbal consent * Prisoners * Unable to take part in research activities via a computer or a smartphone Serious illness experience Inclusion: * Adults aged ≥18 years * Can communicate in English * Able to take part in research activities via a computer or a smartphone * Patients, care partners, clinicians, other healthcare professionals, health policy experts, and community members * Has lived experience or professional expertise relating to serious illness (defined as "a health condition that carries a high risk of mortality and either negatively impacts a person's daily functioning or quality of life or excessively strains his or her caregivers." Exclusion: * Children \<18 years * Cannot communicate in English * Adults unable to provide verbal consent * Prisoners * Unable to take part in research activities via a computer or a smartphone Note: We will not specifically exclude pregnant women, so they may be included incidentally.
Where it's running
-
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire, United States Recruiting -
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States Recruiting
Study contacts
- Study coordinator: Catherine Saunders, Assistant Professor of Medicine, PhD, MPH
- Email: Catherine.Hylas.Saunders@dartmouth.edu
- Phone: 603-650-5402
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Precision navigation to boost cancer screening participation in high-risk communities
This study tests whether a personalized navigation program helps adults aged 45–74 in Chinese communities who are at high risk for several cancers to complete recommended free cancer screenings.
-
Liquid biopsy pre-screen to reduce unnecessary low-dose CT for high-risk lung cancer
This will test a blood-based liquid biopsy to see if it can identify high-risk people who can safely skip or delay a low-dose CT scan for lung cancer.
-
Cervical and endometrial cancer screening for people having gender-affirming hysterectomy
This study will see how often transgender and gender-diverse adults get cervical cancer screening and endometrial sampling before a gender-affirming hysterectomy and whether those tests match what the hysterectomy finds.
-
AI-assisted personalized legacy program — Reflections: My Story
This AI-assisted personalized legacy program tries to help adults with serious illness reflect on their life and create a keepsake document to share with loved ones.
-
Using deep learning and Raman spectroscopy for early cancer diagnosis
This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.